Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Article
|
Associations of type 1 and type 2 diabetes with COVID-19-related mortality in England: a whole-population studyThe Lancet Diabetes & Endocrinology, 2020-10 [Peer Reviewed Journal]2020. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.elsevier.com/legal/elsevier-website-terms-and-conditions ;DOI: 10.1016/S2213-8587(20)30272-2Digital Resources/Online E-Resources |
|
2 |
Material Type: Article
|
Risk factors for COVID-19-related mortality in people with type 1 and type 2 diabetes in England: a population-based cohort studyThe Lancet Diabetes & Endocrinology, 2020-10 [Peer Reviewed Journal]2020. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.elsevier.com/legal/elsevier-website-terms-and-conditions ;DOI: 10.1016/S2213-8587(20)30271-0Digital Resources/Online E-Resources |
|
3 |
Material Type: Article
|
Sedentary behaviour and risk of all-cause, cardiovascular and cancer mortality, and incident type 2 diabetes: a systematic review and dose response meta-analysisEuropean journal of epidemiology, 2018-09, Vol.33 (9), p.811-829 [Peer Reviewed Journal]Springer Nature B.V. 2018 ;The Author(s) 2018 ;European Journal of Epidemiology is a copyright of Springer, (2018). All Rights Reserved. © 2018. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 0393-2990 ;EISSN: 1573-7284 ;DOI: 10.1007/s10654-018-0380-1 ;PMID: 29589226Full text available |
|
4 |
Material Type: Article
|
Liraglutide and Cardiovascular Outcomes in Type 2 DiabetesThe New England journal of medicine, 2016-07, Vol.375 (4), p.311-322 [Peer Reviewed Journal]Copyright © 2016 Massachusetts Medical Society. All rights reserved. ;ISSN: 0028-4793 ;ISSN: 1533-4406 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1603827 ;PMID: 27295427Full text available |
|
5 |
Material Type: Article
|
Clinical Characteristics and Risk Factors for Mortality of COVID-19 Patients With Diabetes in Wuhan, China: A Two-Center, Retrospective StudyDiabetes care, 2020-07, Vol.43 (7), p.1382-1391 [Peer Reviewed Journal]2020 by the American Diabetes Association. ;Copyright American Diabetes Association Jul 1, 2020 ;ISSN: 0149-5992 ;EISSN: 1935-5548 ;DOI: 10.2337/dc20-0598 ;PMID: 32409504Full text available |
|
6 |
Material Type: Article
|
Risk Factors, Mortality, and Cardiovascular Outcomes in Patients with Type 2 DiabetesThe New England journal of medicine, 2018-08, Vol.379 (7), p.633-644 [Peer Reviewed Journal]Copyright © 2018 Massachusetts Medical Society. All rights reserved. ;ISSN: 0028-4793 ;ISSN: 1533-4406 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1800256 ;PMID: 30110583Full text available |
|
7 |
Material Type: Article
|
Canagliflozin and Heart Failure in Type 2 Diabetes Mellitus: Results From the CANVAS ProgramCirculation (New York, N.Y.), 2018-07, Vol.138 (5), p.458-468 [Peer Reviewed Journal]2018 by the American College of Cardiology Foundation and the American Heart Association, Inc. ;2018 The Authors. 2018 ;ISSN: 0009-7322 ;ISSN: 1524-4539 ;EISSN: 1524-4539 ;DOI: 10.1161/CIRCULATIONAHA.118.034222 ;PMID: 29526832Full text available |
|
8 |
Material Type: Article
|
Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 DiabetesThe New England journal of medicine, 2015-11, Vol.373 (22), p.2117-2128 [Peer Reviewed Journal]Copyright © 2015 Massachusetts Medical Society. All rights reserved. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1504720 ;PMID: 26378978Full text available |
|
9 |
Material Type: Article
|
Effect of Dapagliflozin on Heart Failure and Mortality in Type 2 Diabetes MellitusCirculation (New York, N.Y.), 2019-05, Vol.139 (22), p.2528-2536 [Peer Reviewed Journal]2019 by the American College of Cardiology Foundation and the American Heart Association, Inc. ;ISSN: 0009-7322 ;EISSN: 1524-4539 ;DOI: 10.1161/CIRCULATIONAHA.119.040130 ;PMID: 30882238Full text available |
|
10 |
Material Type: Article
|
Excess Mortality among Persons with Type 2 DiabetesThe New England journal of medicine, 2015-10, Vol.373 (18), p.1720-1732 [Peer Reviewed Journal]Copyright © 2015 Massachusetts Medical Society. All rights reserved. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1504347 ;PMID: 26510021Full text available |
|
11 |
Material Type: Article
|
Mortality and Cardiovascular Disease in Type 1 and Type 2 DiabetesThe New England journal of medicine, 2017-04, Vol.376 (15), p.1407-1418 [Peer Reviewed Journal]Copyright © 2017 Massachusetts Medical Society. All rights reserved. ;ISSN: 0028-4793 ;ISSN: 1533-4406 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1608664 ;PMID: 28402770Full text available |
|
12 |
Material Type: Article
|
Lower Risk of Heart Failure and Death in Patients Initiated on Sodium-Glucose Cotransporter-2 Inhibitors Versus Other Glucose-Lowering Drugs: The CVD-REAL Study (Comparative Effectiveness of Cardiovascular Outcomes in New Users of Sodium-Glucose Cotransporter-2 Inhibitors)Circulation (New York, N.Y.), 2017-07, Vol.136 (3), p.249-259 [Peer Reviewed Journal]2017 by the American College of Cardiology Foundation and the American Heart Association, Inc. ;2017 The Authors. ;2017 The Authors. 2017 ;ISSN: 0009-7322 ;ISSN: 1524-4539 ;EISSN: 1524-4539 ;DOI: 10.1161/CIRCULATIONAHA.117.029190 ;PMID: 28522450Full text available |
|
13 |
Material Type: Article
|
How Does Empagliflozin Reduce Cardiovascular Mortality? Insights From a Mediation Analysis of the EMPA-REG OUTCOME TrialDiabetes care, 2018-02, Vol.41 (2), p.356-363 [Peer Reviewed Journal]2017 by the American Diabetes Association. ;Copyright American Diabetes Association Feb 1, 2018 ;ISSN: 0149-5992 ;EISSN: 1935-5548 ;DOI: 10.2337/dc17-1096 ;PMID: 29203583Full text available |
|
14 |
Material Type: Article
|
Risk of Cause-Specific Death in Individuals With Diabetes: A Competing Risks AnalysisDiabetes care, 2016-11, Vol.39 (11), p.1987-1995 [Peer Reviewed Journal]2016 by the American Diabetes Association. ;Copyright American Diabetes Association Nov 1, 2016 ;ISSN: 0149-5992 ;EISSN: 1935-5548 ;DOI: 10.2337/dc16-0614 ;PMID: 27493134 ;CODEN: DICAD2Full text available |
|
15 |
Material Type: Article
|
Insulin Treatment Is Associated with Increased Mortality in Patients with COVID-19 and Type 2 DiabetesCell Metabolism, 2021-01, Vol.33 (1), p.65-77.e2 [Peer Reviewed Journal]2020 Elsevier Inc. ;Copyright © 2020 Elsevier Inc. All rights reserved. ;2020. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.elsevier.com/legal/elsevier-website-terms-and-conditions ;2020 Elsevier Inc. 2020 Elsevier Inc. ;ISSN: 1550-4131 ;EISSN: 1932-7420 ;DOI: 10.1016/j.cmet.2020.11.014 ;PMID: 33248471Digital Resources/Online E-Resources |
|
16 |
Material Type: Article
|
Years of life gained by multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: 21 years follow-up on the Steno-2 randomised trialDiabetologia, 2016-11, Vol.59 (11), p.2298-2307 [Peer Reviewed Journal]The Author(s) 2016 ;Springer-Verlag Berlin Heidelberg 2016 ;ISSN: 0012-186X ;EISSN: 1432-0428 ;DOI: 10.1007/s00125-016-4065-6 ;PMID: 27531506Full text available |
|
17 |
Material Type: Article
|
Prevalence of cardiovascular disease in type 2 diabetes: a systematic literature review of scientific evidence from across the world in 2007-2017Cardiovascular diabetology, 2018-06, Vol.17 (1), p.83-83, Article 83 [Peer Reviewed Journal]Copyright © 2018. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2018 ;ISSN: 1475-2840 ;EISSN: 1475-2840 ;DOI: 10.1186/s12933-018-0728-6 ;PMID: 29884191Full text available |
|
18 |
Material Type: Article
|
Association of Type 2 Diabetes With Cancer: A Meta-analysis With Bias Analysis for Unmeasured Confounding in 151 Cohorts Comprising 32 Million PeopleDiabetes care, 2020-09, Vol.43 (9), p.2313-2322 [Peer Reviewed Journal]2020 by the American Diabetes Association. ;Copyright American Diabetes Association Sep 1, 2020 ;ISSN: 0149-5992 ;EISSN: 1935-5548 ;DOI: 10.2337/dc20-0204 ;PMID: 32910779Full text available |
|
19 |
Material Type: Article
|
Diabetes as a Risk Factor for Poor Early Outcomes in Patients Hospitalized With COVID-19Diabetes care, 2020-12, Vol.43 (12), p.2938-2944 [Peer Reviewed Journal]2020 by the American Diabetes Association. ;Copyright American Diabetes Association Dec 1, 2020 ;2020 by the American Diabetes Association 2020 ;ISSN: 0149-5992 ;EISSN: 1935-5548 ;DOI: 10.2337/dc20-1506 ;PMID: 32847827Full text available |
|
20 |
Material Type: Article
|
Empagliflozin Reduced Mortality and Hospitalization for Heart Failure Across the Spectrum of Cardiovascular Risk in the EMPA-REG OUTCOME TrialCirculation (New York, N.Y.), 2019-03, Vol.139 (11), p.1384-1395 [Peer Reviewed Journal]2019 by the American College of Cardiology Foundation and the American Heart Association, Inc. ;2018 The Authors. 2018 ;ISSN: 0009-7322 ;EISSN: 1524-4539 ;DOI: 10.1161/CIRCULATIONAHA.118.037778 ;PMID: 30586757Full text available |